Eko Analysis Software

Eko Devices Inc · K192004 · 2020-01-15

Eko Analysis Software is an AI-enabled medical device from Eko Devices Inc, listed by FDA (510(k), K192004) with a decision date of 2020-01-15. Review panel: Cardiovascular.

FDA submission numberK192004
Pathway510(k)
CompanyEko Devices Inc
Review panel (specialty)Cardiovascular
FDA decision date2020-01-15
DecisionSubstantially Equivalent
Product codeMWI
ClassificationMonitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)
Device class2
Regulation number870.2300
Review time (calendar days)173
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

All Cardiovascular AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.